Powder for oral solution (Sachets)
Each 1 sachet contains:
Diclofenac potassium 50 mg
1 or 10 sachets
- Short term relief of headache, dental pain, period pain, muscular pain, and the symptoms of colds and flu including fever.
- Rheumatoid arthritis.
- Osteoarthritis.
- Low back pain.
- Migraine attacks.
- Acute musculo-sceletal disorders and trauma such as periathritis (especially frozen shoulder), tendinitis, tenosynovitis, bursitis, sprains, strains and dislocations; relief of pain in fractures.
- Ankylosing spondylitis.
- Acute gout.
- Control of pain and inflammation in orthopaedic, dental and other minor surgeries.
- Pyrophosphate arthropathy and associated disorders.
For oral administration.
The contents of the sachet should be dissolved with stirring in a glass of natural water. The solution may remain slightly opalescent, but this not influences the efficacy of the preparation. The solution should be swallowed preferably before meals.
Undesirable effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms.
Adults:
- The recommended daily dose is 100 – 150 mg in two or three divided doses.
- For milder cases, 75 – 100 mg daily in two or three divided doses is usually sufficient.
- In migraine an initial dose of 50 mg should be taken at the first signs of an impending attack. In cases where relief 2 hours after the first dose is not sufficient, a further dose of 50 mg may be taken. If needed, further doses of 50 mg may be taken at intervals of 4 – 6 hours, not exceeding a total dose of 200 mg per day.
Children:
- For children of 14 years and over, the recommended daily dose is 75 – 100 mg in two or three divided doses.
- Sachet 50 mg is not recommended for use in children and adolescents below 14 years of age.
-The use of Diclofenac Potassium 50 mg in migraine attacks has not been established in children.
Elderly:
The elderlies are at increased risk of the serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patient should be monitored regularly for GI bleeding during NSAID therapy.